filmov
tv
CAR T-Cells: Refining CLL Therapy With Clinical Trials
![preview_player](https://i.ytimg.com/vi/n7lCnYFN7M4/maxresdefault.jpg)
Показать описание
Brian Koffman, MDCM, MSEd, shares insight on his current relapse of chronic lymphocytic leukemia (CLL) and discusses the potential value of chimeric antigen receptor (CAR) T-cell therapy, which he will be receiving in an upcoming clinical trial.
CURE: Combining science and humanity to make cancer understandable.
CURE: Combining science and humanity to make cancer understandable.